|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
3
|
Schabath MB, Nguyen A, Wilson P, Sommerer
KR, Thompson ZJ and Chiappori AA: Temporal trends from 1986 to 2008
in overall survival of small cell lung cancer patients. Lung
Cancer. 86:14–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li C and Hong W: Research status and
funding trends of lung cancer biomarkers. J Thorac Dis. 5:698–705.
2013.PubMed/NCBI
|
|
5
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar :
|
|
10
|
Boeri M, Sestini S, Fortunato O, Verri C,
Suatoni P, Pastorino U and Sozzi G: Recent advances of
microRNA-based molecular diagnostics to reduce false-positive lung
cancer imaging. Expert Rev Mol Diagn. 15:801–813. 2015.PubMed/NCBI
|
|
11
|
Skrzypski M, Dziadziuszko R and Jassem J:
MicroRNA in lung cancer diagnostics and treatment. Mutat Res.
717:25–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guan P, Yin Z, Li X, Wu W and Zhou B:
Meta-analysis of human lung cancer microRNA expression profiling
studies comparing cancer tissues with normal tissues. J Exp Clin
Cancer Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Li ZY, Xu SY, Zhang XJ, Zhang Y,
Luo K and Li WP: Upregulation of miR-107 inhibits glioma
angiogenesis and VEGF expression. Cell Mol Neurobiol. 36:113–120.
2016. View Article : Google Scholar
|
|
14
|
Zhang L, Ma P, Sun LM, Han YC, Li BL, Mi
XY, Wang EH and Song M: MiR-107 down-regulates SIAH1 expression in
human breast cancer cells and silencing of miR-107 inhibits tumor
growth in a nude mouse model of triple-negative breast cancer. Mol
Carcinog. 55:768–777. 2016. View
Article : Google Scholar
|
|
15
|
Zhang M, Wang X, Li W and Cui Y: miR-107
and miR-25 simultaneously target LATS2 and regulate proliferation
and invasion of gastric adenocarcinoma (GAC) cells. Biochem Biophys
Res Commun. 460:806–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou C, Li G, Zhou J, Han N, Liu Z and Yin
J: miR-107 activates ATR/Chk1 pathway and suppress cervical cancer
invasion by targeting MCL1. PLoS One. 9:e1118602014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song N, Ma X, Li H, Zhang Y, Wang X, Zhou
P and Zhang X: microRNA-107 functions as a candidate tumor
suppressor gene in renal clear cell carcinoma involving multiple
genes. Urol Oncol. 33:205.e1–11. 2015. View Article : Google Scholar
|
|
18
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: MiR-107 and miR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Zhang L, Yin ZY, Fan XL, Hu B,
Wang LQ and Zhang D: miR-107 regulates cisplatin chemosensitivity
of A549 non small cell lung cancer cell line by targeting cyclin
dependent kinase 8. Int J Clin Exp Pathol. 7:7236–7241.
2014.PubMed/NCBI
|
|
20
|
Yan H, Wu W, Ge H, Li P and Wang Z:
Up-regulation of miR-204 enhances anoikis sensitivity in epithelial
ovarian cancer cell line via brain-derived neurotrophic factor
pathway in vitro. Int J Gynecol Cancer. 25:944–952. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao XY, Zhou HH, Li X and Liu ZQ:
Huperzine A alleviates oxidative glutamate toxicity in hippocampal
HT22 cells via activating BDNF/TrkB-dependent PI3K/Akt/mTOR
signaling pathway. Cell Mol Neurobiol. 36:915–925. 2016. View Article : Google Scholar
|
|
22
|
Huang H, Zhong R, Xia Z, Song J and Feng
L: Neuroprotective effects of rhynchophylline against ischemic
brain injury via regulation of the Akt/mTOR and TLRs signaling
pathways. Molecules. 19:11196–11210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong KZ, Chen WW, Hu XY, Jiang AL and
Zhao J: Clinicopathological and prognostic significance of
microRNA-107 in human non-small cell lung cancer. Int J Clin Exp
Pathol. 7:4545–4551. 2014.
|
|
24
|
Ristori E, Lopez-Ramirez MA, Narayanan A,
Hill-Teran G, Moro A, Calvo CF, Thomas JL and Nicoli S: A
Dicer-miR-107 interaction regulates biogenesis of specific miRNAs
crucial for neurogenesis. Dev Cell. 32:546–560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang JJ, Wang CY, Hua L, Yao KH, Chen JT
and Hu JH: miR-107 promotes hepatocellular carcinoma cell
proliferation by targeting Axin2. Int J Clin Exp Pathol.
8:5168–5174. 2015.PubMed/NCBI
|
|
26
|
McAllister AK: Neurotrophins and neuronal
differentiation in the central nervous system. Cell Mol Life Sci.
58:1054–1060. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arévalo JC and Wu SH: Neurotrophin
signaling: Many exciting surprises! Cell Mol Life Sci.
63:1523–1537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sandhya VK, Raju R, Verma R, Advani J,
Sharma R, Radhakrishnan A, Nanjappa V, Narayana J, Somani BL,
Mukherjee KK, et al: A network map of BDNF/TRKB and BDNF/p75NTR
signaling system. J Cell Commun Signal. 7:301–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De la Cruz-Morcillo MA, Berger J,
Sánchez-Prieto R, Saada S, Naves T, Guillaudeau A, Perraud A,
Sindou P, Lacroix A, Descazeaud A, et al: p75 neurotrophin receptor
and pro-BDNF promote cell survival and migration in clear cell
renal cell carcinoma. Oncotarget. Apr 22–2016.(Epub ahead of
print). PubMed/NCBI
|
|
30
|
Kang HJ, Kim JM, Kim SY, Kim SW, Shin IS,
Kim HR, Park MH, Shin MG, Yoon JH and Yoon JS: A Longitudinal study
of BDNF promoter methylation and depression in breast cancer.
Psychiatry Investig. 12:523–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang SM, Lin C, Lin HY, Chiu CM, Fang CW,
Liao KF, Chen DR and Yeh WL: Brain-derived neurotrophic factor
regulates cell motility in human colon cancer. Endocr Relat Cancer.
22:455–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tanaka K, Okugawa Y, Toiyama Y, Inoue Y,
Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y and Kusunoki M:
Brain-derived neurotrophic factor (BDNF)-induced
tropomyosin-related kinase B (Trk B) signaling is a potential
therapeutic target for peritoneal carcinomatosis arising from
colorectal cancer. PLoS One. 9:e964102014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaplan DR, Matsumoto K, Lucarelli E and
Thiele CJ; Eukaryotic Signal Transduction Group. Induction of TrkB
by retinoic acid mediates biologic responsiveness to BDNF and
differentiation of human neuroblastoma cells. Neuron. 11:321–331.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Okamura K, Harada T, Wang S, Ijichi K,
Furuyama K, Koga T, Okamoto T, Takayama K, Yano T and Nakanishi Y:
Expression of TrkB and BDNF is associated with poor prognosis in
non-small cell lung cancer. Lung Cancer. 78:100–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang SY, Hui LP, Li CY, Gao J, Cui ZS and
Qiu XS: More expression of BDNF associates with lung squamous cell
carcinoma and is critical to the proliferation and invasion of lung
cancer cells. BMC Cancer. 16:1712016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang S, Guo D, Luo W, Zhang Q, Zhang Y,
Li C, Lu Y, Cui Z and Qiu X: TrkB is highly expressed in NSCLC and
mediates BDNF-induced the activation of Pyk2 signaling and the
invasion of A549 cells. BMC Cancer. 10:432010. View Article : Google Scholar : PubMed/NCBI
|
